{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5079, "recent_count": 2594, "transaction_limit": 160, "filters": {"q": "", "ticker": "", "sector": "Healthcare", "industry": "Biotechnology", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 2594, "acquisition_count": 1122, "disposal_count": 1472, "acquisition_value": 64364050.2779, "acquisition_value_label": "$64.4M", "disposal_value": 2964382851.9383, "disposal_value_label": "$3.0B", "net_value": -2900018801.6604, "net_value_label": "$-2.9B", "flow_tone": "negative", "largest_value_label": "$1.0B", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 2594, "value": "3028746902.2162", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$3.0B"}], "days": [{"transaction_date": "2026-07-08", "acquisitions": 26, "disposals": 19, "total": 45, "bar_width": 12.2}, {"transaction_date": "2026-07-09", "acquisitions": 21, "disposals": 27, "total": 48, "bar_width": 13.0}, {"transaction_date": "2026-07-10", "acquisitions": 8, "disposals": 9, "total": 17, "bar_width": 4.6}, {"transaction_date": "2026-07-13", "acquisitions": 7, "disposals": 5, "total": 12, "bar_width": 3.3}, {"transaction_date": "2026-07-14", "acquisitions": 10, "disposals": 90, "total": 100, "bar_width": 27.1}, {"transaction_date": "2026-07-15", "acquisitions": 58, "disposals": 311, "total": 369, "bar_width": 100.0}, {"transaction_date": "2026-07-16", "acquisitions": 56, "disposals": 16, "total": 72, "bar_width": 19.5}, {"transaction_date": "2026-07-17", "acquisitions": 14, "disposals": 5, "total": 19, "bar_width": 5.1}, {"transaction_date": "2026-07-19", "acquisitions": 3, "disposals": 5, "total": 8, "bar_width": 2.2}, {"transaction_date": "2026-07-20", "acquisitions": 6, "disposals": 16, "total": 22, "bar_width": 6.0}, {"transaction_date": "2026-07-21", "acquisitions": 6, "disposals": 5, "total": 11, "bar_width": 3.0}, {"transaction_date": "2026-07-22", "acquisitions": 4, "disposals": 8, "total": 12, "bar_width": 3.3}, {"transaction_date": "2026-07-23", "acquisitions": 2, "disposals": 11, "total": 13, "bar_width": 3.5}, {"transaction_date": "2026-07-24", "acquisitions": 3, "disposals": 3, "total": 6, "bar_width": 1.6}], "side_mix": {"acquisitions": 1122, "disposals": 1472, "acquisition_share": 43.3, "disposal_share": 56.7}}, "company_flows": [{"symbol": "DYAI", "name": "Dyadic International Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-24", "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 124957.912, "disposed_value_label": "$125.0K", "net_value": -124957.912, "net_value_label": "$-125.0K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/dyai/", "research_links": {"chart": "/terminal/0df9ea28-5d7a-45f2-895e-d7204e29445f/", "report": "/terminal/0df9ea28-5d7a-45f2-895e-d7204e29445f/report/", "factor": "/factors/ticker/0df9ea28-5d7a-45f2-895e-d7204e29445f/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-23", "acquisitions": 0, "disposals": 8, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 139507.4712, "disposed_value_label": "$139.5K", "net_value": -139507.4712, "net_value_label": "$-139.5K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "ATRA", "name": "Atara Biotherapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-22", "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/atra/", "research_links": {"chart": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/", "report": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/report/", "factor": "/factors/ticker/61910527-1c5c-4eb2-89ea-15ea913b9982/"}}, {"symbol": "NTLA", "name": "Intellia Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-22", "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 219750.73, "disposed_value_label": "$219.8K", "net_value": -219750.73, "net_value_label": "$-219.8K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/ntla/", "research_links": {"chart": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/", "report": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/report/", "factor": "/factors/ticker/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/"}}, {"symbol": "SRZN", "name": "Surrozen Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-22", "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 3453125.0, "disposed_value_label": "$3.5M", "net_value": -3453125.0, "net_value_label": "$-3.5M", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/srzn/", "research_links": {"chart": "/terminal/23b8ba9d-c1a6-4d8a-949d-a02dca1e8a5a/", "report": "/terminal/23b8ba9d-c1a6-4d8a-949d-a02dca1e8a5a/report/", "factor": "/factors/ticker/23b8ba9d-c1a6-4d8a-949d-a02dca1e8a5a/"}}, {"symbol": "ABEO", "name": "Abeona Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-21", "acquisitions": 0, "disposals": 6, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 893021.8359, "disposed_value_label": "$893.0K", "net_value": -893021.8359, "net_value_label": "$-893.0K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/abeo/", "research_links": {"chart": "/terminal/6e8cdb5b-8663-41f7-9494-52144fcbd685/", "report": "/terminal/6e8cdb5b-8663-41f7-9494-52144fcbd685/report/", "factor": "/factors/ticker/6e8cdb5b-8663-41f7-9494-52144fcbd685/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-19", "acquisitions": 0, "disposals": 5, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1034.94, "disposed_value_label": "$1.0K", "net_value": -1034.94, "net_value_label": "$-1.0K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "DNA", "name": "Ginkgo Bioworks Holdings", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 5943.056, "disposed_value_label": "$5.9K", "net_value": -5943.056, "net_value_label": "$-5.9K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/dna/", "research_links": {"chart": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/", "report": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/report/", "factor": "/factors/ticker/3264af35-eb5a-4c64-8c7b-379213ed9bd9/"}}, {"symbol": "LYEL", "name": "Lyell Immunopharma Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 274.3, "disposed_value_label": "$274", "net_value": -274.3, "net_value_label": "$-274", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/lyel/", "research_links": {"chart": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/", "report": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/report/", "factor": "/factors/ticker/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/"}}, {"symbol": "CPRX", "name": "Catalyst Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-15", "acquisitions": 0, "disposals": 127, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 212759631.0, "disposed_value_label": "$212.8M", "net_value": -212759631.0, "net_value_label": "$-212.8M", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/cprx/", "research_links": {"chart": "/terminal/555105cb-5a62-4703-91b8-b419ded90f2c/", "report": "/terminal/555105cb-5a62-4703-91b8-b419ded90f2c/report/", "factor": "/factors/ticker/555105cb-5a62-4703-91b8-b419ded90f2c/"}}, {"symbol": "PTN", "name": "Palatin Technologies, Inc. Common Stock", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-15", "acquisitions": 0, "disposals": 6, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 6352.15, "disposed_value_label": "$6.4K", "net_value": -6352.15, "net_value_label": "$-6.4K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/ptn/", "research_links": {"chart": "/terminal/d690d1f2-c6ad-43ae-bc45-030768e8fa28/", "report": "/terminal/d690d1f2-c6ad-43ae-bc45-030768e8fa28/report/", "factor": "/factors/ticker/d690d1f2-c6ad-43ae-bc45-030768e8fa28/"}}, {"symbol": "CELC", "name": "Celcuity LLC", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-14", "acquisitions": 0, "disposals": 2, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 317750000.0, "disposed_value_label": "$317.8M", "net_value": -317750000.0, "net_value_label": "$-317.8M", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/celc/", "research_links": {"chart": "/terminal/c797b78b-4fee-4542-836b-4cb097d61c43/", "report": "/terminal/c797b78b-4fee-4542-836b-4cb097d61c43/report/", "factor": "/factors/ticker/c797b78b-4fee-4542-836b-4cb097d61c43/"}}, {"symbol": "PHAT", "name": "Phathom Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-14", "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 17159.425, "disposed_value_label": "$17.2K", "net_value": -17159.425, "net_value_label": "$-17.2K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/phat/", "research_links": {"chart": "/terminal/4b38f0b4-52fe-4af6-be6b-232eda56775d/", "report": "/terminal/4b38f0b4-52fe-4af6-be6b-232eda56775d/report/", "factor": "/factors/ticker/4b38f0b4-52fe-4af6-be6b-232eda56775d/"}}, {"symbol": "XOMA", "name": "XOMA Royalty Corporation", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-14", "acquisitions": 0, "disposals": 53, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/xoma/", "research_links": {"chart": "/terminal/61cdb5df-b2b3-498c-99fe-f44983250901/", "report": "/terminal/61cdb5df-b2b3-498c-99fe-f44983250901/report/", "factor": "/factors/ticker/61cdb5df-b2b3-498c-99fe-f44983250901/"}}, {"symbol": "RCUS", "name": "Arcus Biosciences Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-10", "acquisitions": 0, "disposals": 7, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 2909420.0442, "disposed_value_label": "$2.9M", "net_value": -2909420.0442, "net_value_label": "$-2.9M", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/rcus/", "research_links": {"chart": "/terminal/bcb67560-2ecc-4e50-a0b7-07e5a42bb64a/", "report": "/terminal/bcb67560-2ecc-4e50-a0b7-07e5a42bb64a/report/", "factor": "/factors/ticker/bcb67560-2ecc-4e50-a0b7-07e5a42bb64a/"}}, {"symbol": "TSHA", "name": "Taysha Gene Therapies\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-10", "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1248000.0, "disposed_value_label": "$1.2M", "net_value": -1248000.0, "net_value_label": "$-1.2M", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/tsha/", "research_links": {"chart": "/terminal/79bd998f-0c56-4104-a5e0-7fb5bb1e2945/", "report": "/terminal/79bd998f-0c56-4104-a5e0-7fb5bb1e2945/report/", "factor": "/factors/ticker/79bd998f-0c56-4104-a5e0-7fb5bb1e2945/"}}, {"symbol": "MRVI", "name": "Maravai Lifesciences Holdings\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-08", "acquisitions": 0, "disposals": 2, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 592241.76, "disposed_value_label": "$592.2K", "net_value": -592241.76, "net_value_label": "$-592.2K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/mrvi/", "research_links": {"chart": "/terminal/ba85fc2a-c03e-495a-b560-6f25e5dc49d8/", "report": "/terminal/ba85fc2a-c03e-495a-b560-6f25e5dc49d8/report/", "factor": "/factors/ticker/ba85fc2a-c03e-495a-b560-6f25e5dc49d8/"}}, {"symbol": "SEER", "name": "Seer\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-08", "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 23265.45, "disposed_value_label": "$23.3K", "net_value": -23265.45, "net_value_label": "$-23.3K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/seer/", "research_links": {"chart": "/terminal/65216e94-b006-47cc-8c16-cbfdc1ca1ff4/", "report": "/terminal/65216e94-b006-47cc-8c16-cbfdc1ca1ff4/report/", "factor": "/factors/ticker/65216e94-b006-47cc-8c16-cbfdc1ca1ff4/"}}, {"symbol": "HOWL", "name": "Werewolf Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-07", "acquisitions": 0, "disposals": 5, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 237793.44, "disposed_value_label": "$237.8K", "net_value": -237793.44, "net_value_label": "$-237.8K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/howl/", "research_links": {"chart": "/terminal/1c21f044-d0ca-4c28-ae24-6beaea5b60b7/", "report": "/terminal/1c21f044-d0ca-4c28-ae24-6beaea5b60b7/report/", "factor": "/factors/ticker/1c21f044-d0ca-4c28-ae24-6beaea5b60b7/"}}, {"symbol": "VERA", "name": "Vera Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-07", "acquisitions": 0, "disposals": 6, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 2657956.3732, "disposed_value_label": "$2.7M", "net_value": -2657956.3732, "net_value_label": "$-2.7M", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/vera/", "research_links": {"chart": "/terminal/4c1c9d9b-6910-4e53-9189-ad6ee63a30cb/", "report": "/terminal/4c1c9d9b-6910-4e53-9189-ad6ee63a30cb/report/", "factor": "/factors/ticker/4c1c9d9b-6910-4e53-9189-ad6ee63a30cb/"}}, {"symbol": "ORIC", "name": "Oric Pharmaceuticals\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-06", "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 3600.0, "disposed_value_label": "$3.6K", "net_value": -3600.0, "net_value_label": "$-3.6K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/oric/", "research_links": {"chart": "/terminal/e3cdb4a9-b940-4cea-8d7c-0f662e2ac923/", "report": "/terminal/e3cdb4a9-b940-4cea-8d7c-0f662e2ac923/report/", "factor": "/factors/ticker/e3cdb4a9-b940-4cea-8d7c-0f662e2ac923/"}}, {"symbol": "PBYI", "name": "Puma Biotechnology Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-06", "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 511512.752, "disposed_value_label": "$511.5K", "net_value": -511512.752, "net_value_label": "$-511.5K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/pbyi/", "research_links": {"chart": "/terminal/21297a09-aa9b-4ab4-b13f-c095f19876b9/", "report": "/terminal/21297a09-aa9b-4ab4-b13f-c095f19876b9/report/", "factor": "/factors/ticker/21297a09-aa9b-4ab4-b13f-c095f19876b9/"}}, {"symbol": "MDXG", "name": "MiMedx Group Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-02", "acquisitions": 0, "disposals": 2, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 126269.15, "disposed_value_label": "$126.3K", "net_value": -126269.15, "net_value_label": "$-126.3K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/mdxg/", "research_links": {"chart": "/terminal/7a75f9c4-6c06-4196-b76a-3dca72c1f3c9/", "report": "/terminal/7a75f9c4-6c06-4196-b76a-3dca72c1f3c9/report/", "factor": "/factors/ticker/7a75f9c4-6c06-4196-b76a-3dca72c1f3c9/"}}, {"symbol": "REGN", "name": "Regeneron Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-02", "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 130030.0, "disposed_value_label": "$130.0K", "net_value": -130030.0, "net_value_label": "$-130.0K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/regn/", "research_links": {"chart": "/terminal/1c42d613-c405-45d7-9f43-f2050c317cb4/", "report": "/terminal/1c42d613-c405-45d7-9f43-f2050c317cb4/report/", "factor": "/factors/ticker/1c42d613-c405-45d7-9f43-f2050c317cb4/"}}], "company_overview": [{"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-24", "filings": 32, "acquisitions": 5, "disposals": 27, "acquired_value": 1788253.28, "acquired_value_label": "$1.8M", "disposed_value": 7551053.98, "disposed_value_label": "$7.6M", "net_value": -5762800.7, "net_value_label": "$-5.8M", "acquisition_share": 15.6, "disposal_share": 84.4, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "NKTR", "name": "Nektar Therapeutics", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-24", "filings": 5, "acquisitions": 2, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1009550.0, "disposed_value_label": "$1.0M", "net_value": -1009550.0, "net_value_label": "$-1.0M", "acquisition_share": 40.0, "disposal_share": 60.0, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/nktr/", "research_links": {"chart": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/", "report": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/report/", "factor": "/factors/ticker/2b54e02b-1441-43ca-8cf6-5798bc73166f/"}}, {"symbol": "DYAI", "name": "Dyadic International Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-24", "filings": 3, "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 124957.912, "disposed_value_label": "$125.0K", "net_value": -124957.912, "net_value_label": "$-125.0K", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/dyai/", "research_links": {"chart": "/terminal/0df9ea28-5d7a-45f2-895e-d7204e29445f/", "report": "/terminal/0df9ea28-5d7a-45f2-895e-d7204e29445f/report/", "factor": "/factors/ticker/0df9ea28-5d7a-45f2-895e-d7204e29445f/"}}, {"symbol": "INSM", "name": "Insmed Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-23", "filings": 31, "acquisitions": 10, "disposals": 21, "acquired_value": 1384833.65, "acquired_value_label": "$1.4M", "disposed_value": 6127720.19, "disposed_value_label": "$6.1M", "net_value": -4742886.54, "net_value_label": "$-4.7M", "acquisition_share": 32.3, "disposal_share": 67.7, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/insm/", "research_links": {"chart": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/", "report": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/report/", "factor": "/factors/ticker/4462d582-ffa0-4ad8-8e28-dc0a53589a12/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-23", "filings": 8, "acquisitions": 0, "disposals": 8, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 139507.4712, "disposed_value_label": "$139.5K", "net_value": -139507.4712, "net_value_label": "$-139.5K", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "MLTX", "name": "MoonLake Immunotherapeutics", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-22", "filings": 16, "acquisitions": 5, "disposals": 11, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 7438573.4, "disposed_value_label": "$7.4M", "net_value": -7438573.4, "net_value_label": "$-7.4M", "acquisition_share": 31.2, "disposal_share": 68.8, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/mltx/", "research_links": {"chart": "/terminal/00c0ba0e-839d-4b83-8101-db908d22fc0b/", "report": "/terminal/00c0ba0e-839d-4b83-8101-db908d22fc0b/report/", "factor": "/factors/ticker/00c0ba0e-839d-4b83-8101-db908d22fc0b/"}}, {"symbol": "OMER", "name": "Omeros Corporation", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-22", "filings": 10, "acquisitions": 10, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/omer/", "research_links": {"chart": "/terminal/b322b82e-6812-408f-9c42-41c81bec7c83/", "report": "/terminal/b322b82e-6812-408f-9c42-41c81bec7c83/report/", "factor": "/factors/ticker/b322b82e-6812-408f-9c42-41c81bec7c83/"}}, {"symbol": "ATRA", "name": "Atara Biotherapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-22", "filings": 5, "acquisitions": 1, "disposals": 4, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 20.0, "disposal_share": 80.0, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/atra/", "research_links": {"chart": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/", "report": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/report/", "factor": "/factors/ticker/61910527-1c5c-4eb2-89ea-15ea913b9982/"}}, {"symbol": "NTLA", "name": "Intellia Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-22", "filings": 3, "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 219750.73, "disposed_value_label": "$219.8K", "net_value": -219750.73, "net_value_label": "$-219.8K", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/ntla/", "research_links": {"chart": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/", "report": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/report/", "factor": "/factors/ticker/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/"}}, {"symbol": "SRZN", "name": "Surrozen Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-22", "filings": 1, "acquisitions": 0, "disposals": 1, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 3453125.0, "disposed_value_label": "$3.5M", "net_value": -3453125.0, "net_value_label": "$-3.5M", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/srzn/", "research_links": {"chart": "/terminal/23b8ba9d-c1a6-4d8a-949d-a02dca1e8a5a/", "report": "/terminal/23b8ba9d-c1a6-4d8a-949d-a02dca1e8a5a/report/", "factor": "/factors/ticker/23b8ba9d-c1a6-4d8a-949d-a02dca1e8a5a/"}}, {"symbol": "CYTK", "name": "Cytokinetics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-21", "filings": 48, "acquisitions": 22, "disposals": 26, "acquired_value": 2542027.7, "acquired_value_label": "$2.5M", "disposed_value": 6954061.48, "disposed_value_label": "$7.0M", "net_value": -4412033.78, "net_value_label": "$-4.4M", "acquisition_share": 45.8, "disposal_share": 54.2, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/cytk/", "research_links": {"chart": "/terminal/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/", "report": "/terminal/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/report/", "factor": "/factors/ticker/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/"}}, {"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-21", "filings": 9, "acquisitions": 4, "disposals": 5, "acquired_value": 62499.7953, "acquired_value_label": "$62.5K", "disposed_value": 2762491.28, "disposed_value_label": "$2.8M", "net_value": -2699991.4847, "net_value_label": "$-2.7M", "acquisition_share": 44.4, "disposal_share": 55.6, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}, {"symbol": "MGTX", "name": "MeiraGTx Holdings PLC", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-21", "filings": 8, "acquisitions": 5, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1110030.22, "disposed_value_label": "$1.1M", "net_value": -1110030.22, "net_value_label": "$-1.1M", "acquisition_share": 62.5, "disposal_share": 37.5, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/mgtx/", "research_links": {"chart": "/terminal/c17b2e70-74a3-4bc4-a406-6ee0fb32abf1/", "report": "/terminal/c17b2e70-74a3-4bc4-a406-6ee0fb32abf1/report/", "factor": "/factors/ticker/c17b2e70-74a3-4bc4-a406-6ee0fb32abf1/"}}, {"symbol": "ABEO", "name": "Abeona Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-21", "filings": 6, "acquisitions": 0, "disposals": 6, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 893021.8359, "disposed_value_label": "$893.0K", "net_value": -893021.8359, "net_value_label": "$-893.0K", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/abeo/", "research_links": {"chart": "/terminal/6e8cdb5b-8663-41f7-9494-52144fcbd685/", "report": "/terminal/6e8cdb5b-8663-41f7-9494-52144fcbd685/report/", "factor": "/factors/ticker/6e8cdb5b-8663-41f7-9494-52144fcbd685/"}}, {"symbol": "RANI", "name": "Rani Therapeutics Holdings Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-21", "filings": 3, "acquisitions": 3, "disposals": 0, "acquired_value": 50033.0, "acquired_value_label": "$50.0K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 50033.0, "net_value_label": "$50.0K", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/rani/", "research_links": {"chart": "/terminal/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/", "report": "/terminal/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/report/", "factor": "/factors/ticker/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/"}}, {"symbol": "OTLK", "name": "OUTLOOK THERAPEUTICS INC", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-21", "filings": 2, "acquisitions": 2, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/otlk/", "research_links": {"chart": "/terminal/428d3268-e95e-4507-abb1-f58bce42dc91/", "report": "/terminal/428d3268-e95e-4507-abb1-f58bce42dc91/report/", "factor": "/factors/ticker/428d3268-e95e-4507-abb1-f58bce42dc91/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-20", "filings": 24, "acquisitions": 13, "disposals": 11, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1368253.4529, "disposed_value_label": "$1.4M", "net_value": -1368253.4529, "net_value_label": "$-1.4M", "acquisition_share": 54.2, "disposal_share": 45.8, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-20", "filings": 13, "acquisitions": 4, "disposals": 9, "acquired_value": 1642100.0, "acquired_value_label": "$1.6M", "disposed_value": 4393814.9, "disposed_value_label": "$4.4M", "net_value": -2751714.9, "net_value_label": "$-2.8M", "acquisition_share": 30.8, "disposal_share": 69.2, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "ANIX", "name": "Anixa Biosciences Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-20", "filings": 4, "acquisitions": 4, "disposals": 0, "acquired_value": 83314.16, "acquired_value_label": "$83.3K", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 83314.16, "net_value_label": "$83.3K", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/anix/", "research_links": {"chart": "/terminal/01375501-71ca-44d9-ab28-f75ee33bd267/", "report": "/terminal/01375501-71ca-44d9-ab28-f75ee33bd267/report/", "factor": "/factors/ticker/01375501-71ca-44d9-ab28-f75ee33bd267/"}}, {"symbol": "JSPR", "name": "Jasper Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-20", "filings": 3, "acquisitions": 3, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/jspr/", "research_links": {"chart": "/terminal/e6bc52d4-759d-4082-a252-e3fd6873465d/", "report": "/terminal/e6bc52d4-759d-4082-a252-e3fd6873465d/report/", "factor": "/factors/ticker/e6bc52d4-759d-4082-a252-e3fd6873465d/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-19", "filings": 8, "acquisitions": 3, "disposals": 5, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1034.94, "disposed_value_label": "$1.0K", "net_value": -1034.94, "net_value_label": "$-1.0K", "acquisition_share": 37.5, "disposal_share": 62.5, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "filings": 41, "acquisitions": 8, "disposals": 33, "acquired_value": 4787165.0, "acquired_value_label": "$4.8M", "disposed_value": 202808518.38, "disposed_value_label": "$202.8M", "net_value": -198021353.38, "net_value_label": "$-198.0M", "acquisition_share": 19.5, "disposal_share": 80.5, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "MNKD", "name": "MannKind Corp", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "filings": 34, "acquisitions": 5, "disposals": 29, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 2864911.01, "disposed_value_label": "$2.9M", "net_value": -2864911.01, "net_value_label": "$-2.9M", "acquisition_share": 14.7, "disposal_share": 85.3, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/mnkd/", "research_links": {"chart": "/terminal/ea6f90ee-f127-429e-b2af-8d9e4052576e/", "report": "/terminal/ea6f90ee-f127-429e-b2af-8d9e4052576e/report/", "factor": "/factors/ticker/ea6f90ee-f127-429e-b2af-8d9e4052576e/"}}, {"symbol": "BCDA", "name": "Biocardia\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "filings": 26, "acquisitions": 23, "disposals": 3, "acquired_value": 374934.1, "acquired_value_label": "$374.9K", "disposed_value": 117800.0, "disposed_value_label": "$117.8K", "net_value": 257134.1, "net_value_label": "$257.1K", "acquisition_share": 88.5, "disposal_share": 11.5, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/bcda/", "research_links": {"chart": "/terminal/fa621307-fa10-49b7-8abf-d5cc5855702d/", "report": "/terminal/fa621307-fa10-49b7-8abf-d5cc5855702d/report/", "factor": "/factors/ticker/fa621307-fa10-49b7-8abf-d5cc5855702d/"}}, {"symbol": "FULC", "name": "Fulcrum Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "filings": 15, "acquisitions": 14, "disposals": 1, "acquired_value": 1485742.64, "acquired_value_label": "$1.5M", "disposed_value": 65613.6, "disposed_value_label": "$65.6K", "net_value": 1420129.04, "net_value_label": "$1.4M", "acquisition_share": 93.3, "disposal_share": 6.7, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/fulc/", "research_links": {"chart": "/terminal/b9bb7bef-e478-4ef9-ada9-0036dc78ff25/", "report": "/terminal/b9bb7bef-e478-4ef9-ada9-0036dc78ff25/report/", "factor": "/factors/ticker/b9bb7bef-e478-4ef9-ada9-0036dc78ff25/"}}, {"symbol": "ARTL", "name": "Artelo Biosciences Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "filings": 6, "acquisitions": 6, "disposals": 0, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 100.0, "disposal_share": 0.0, "tone": "Acquisition-led", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/artl/", "research_links": {"chart": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/", "report": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/report/", "factor": "/factors/ticker/08f21f1a-3a3b-4928-aeda-4b66067c72ea/"}}, {"symbol": "DNA", "name": "Ginkgo Bioworks Holdings", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NYSE", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "filings": 5, "acquisitions": 2, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 5943.056, "disposed_value_label": "$5.9K", "net_value": -5943.056, "net_value_label": "$-5.9K", "acquisition_share": 40.0, "disposal_share": 60.0, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/dna/", "research_links": {"chart": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/", "report": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/report/", "factor": "/factors/ticker/3264af35-eb5a-4c64-8c7b-379213ed9bd9/"}}, {"symbol": "LYEL", "name": "Lyell Immunopharma Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-17", "filings": 3, "acquisitions": 0, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 274.3, "disposed_value_label": "$274", "net_value": -274.3, "net_value_label": "$-274", "acquisition_share": 0.0, "disposal_share": 100.0, "tone": "Disposal-led", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/lyel/", "research_links": {"chart": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/", "report": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/report/", "factor": "/factors/ticker/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-16", "filings": 45, "acquisitions": 29, "disposals": 16, "acquired_value": 57473.52, "acquired_value_label": "$57.5K", "disposed_value": 10496539.24, "disposed_value_label": "$10.5M", "net_value": -10439065.72, "net_value_label": "$-10.4M", "acquisition_share": 64.4, "disposal_share": 35.6, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-16", "filings": 38, "acquisitions": 12, "disposals": 26, "acquired_value": 539941.83, "acquired_value_label": "$539.9K", "disposed_value": 2047116.5938, "disposed_value_label": "$2.0M", "net_value": -1507174.7638, "net_value_label": "$-1.5M", "acquisition_share": 31.6, "disposal_share": 68.4, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}], "transactions": [{"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1500.0, "share_price": 39.8, "transaction_value": 59700.0, "fetched_at": "2026-07-30T21:54:23.859470+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1500.0, "share_price": 8.43, "transaction_value": 12645.0, "fetched_at": "2026-07-30T21:54:23.865703+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "DYAI", "name": "Dyadic International Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "FRANCISCO, TRUST UNDER AGREEMENT DATED FEBRUARY 28, 1996", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2616.0, "share_price": 1.2131, "transaction_value": 3173.4696, "fetched_at": "2026-07-30T10:57:47.048370+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyai/", "research_links": {"chart": "/terminal/0df9ea28-5d7a-45f2-895e-d7204e29445f/", "report": "/terminal/0df9ea28-5d7a-45f2-895e-d7204e29445f/report/", "factor": "/factors/ticker/0df9ea28-5d7a-45f2-895e-d7204e29445f/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "PANDE, ATUL", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 1500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:54:23.868367+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "NKTR", "name": "Nektar Therapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "ROBIN, HOWARD W", "executive_title": "Director, President & CEO", "security_type": "Stock Option", "side_code": "A", "side": "Acquisition", "shares": 57200.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T22:09:00.627652+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nktr/", "research_links": {"chart": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/", "report": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/report/", "factor": "/factors/ticker/2b54e02b-1441-43ca-8cf6-5798bc73166f/"}}, {"symbol": "NKTR", "name": "Nektar Therapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "ZALEVSKY, JONATHAN", "executive_title": "Chief R&D Officer", "security_type": "Stock Option", "side_code": "A", "side": "Acquisition", "shares": 16500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T22:09:00.616325+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nktr/", "research_links": {"chart": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/", "report": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/report/", "factor": "/factors/ticker/2b54e02b-1441-43ca-8cf6-5798bc73166f/"}}, {"symbol": "INSM", "name": "Insmed Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "LEWIS, WILLIAM", "executive_title": "Director, Chair and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5872.0, "share_price": 106.43, "transaction_value": 624956.96, "fetched_at": "2026-07-30T11:10:02.763241+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/insm/", "research_links": {"chart": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/", "report": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/report/", "factor": "/factors/ticker/4462d582-ffa0-4ad8-8e28-dc0a53589a12/"}}, {"symbol": "INSM", "name": "Insmed Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "LEWIS, WILLIAM", "executive_title": "Director, Chair and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 4828.0, "share_price": 105.62, "transaction_value": 509933.36, "fetched_at": "2026-07-30T11:10:02.765411+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/insm/", "research_links": {"chart": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/", "report": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/report/", "factor": "/factors/ticker/4462d582-ffa0-4ad8-8e28-dc0a53589a12/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "GIRAO, TIAGO", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 6798.0, "share_price": 38.69, "transaction_value": 263014.62, "fetched_at": "2026-07-30T21:54:23.870005+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "INSM", "name": "Insmed Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "LEWIS, WILLIAM", "executive_title": "Director, Chair and CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 6260.0, "share_price": 30.46, "transaction_value": 190679.6, "fetched_at": "2026-07-30T11:10:02.749451+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/insm/", "research_links": {"chart": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/", "report": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/report/", "factor": "/factors/ticker/4462d582-ffa0-4ad8-8e28-dc0a53589a12/"}}, {"symbol": "IMVT", "name": "Immunovant\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "STOUT, JAY S", "executive_title": "Chief Technology Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2857.0, "share_price": 38.69, "transaction_value": 110537.33, "fetched_at": "2026-07-30T21:54:23.871339+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imvt/", "research_links": {"chart": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/", "report": "/terminal/5eec2eb7-c752-428d-aacf-90e20518de10/report/", "factor": "/factors/ticker/5eec2eb7-c752-428d-aacf-90e20518de10/"}}, {"symbol": "INSM", "name": "Insmed Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "LEWIS, WILLIAM", "executive_title": "Director, Chair and CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 4440.0, "share_price": 17.16, "transaction_value": 76190.4, "fetched_at": "2026-07-30T11:10:02.767238+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/insm/", "research_links": {"chart": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/", "report": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/report/", "factor": "/factors/ticker/4462d582-ffa0-4ad8-8e28-dc0a53589a12/"}}, {"symbol": "DYAI", "name": "Dyadic International Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "FRANCISCO, TRUST UNDER AGREEMENT DATED FEBRUARY 28, 1996", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 54760.0, "share_price": 1.3021, "transaction_value": 71302.996, "fetched_at": "2026-07-30T10:57:47.051911+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyai/", "research_links": {"chart": "/terminal/0df9ea28-5d7a-45f2-895e-d7204e29445f/", "report": "/terminal/0df9ea28-5d7a-45f2-895e-d7204e29445f/report/", "factor": "/factors/ticker/0df9ea28-5d7a-45f2-895e-d7204e29445f/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "DOMZALSKI, DAVID", "executive_title": "Director, PRESIDENT AND CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 79391.0, "share_price": 0.8976, "transaction_value": 71261.3616, "fetched_at": "2026-07-30T10:58:50.941093+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "HARSCH, MUTYA", "executive_title": "CHIEF LEGAL OFFICER AND GC", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 22516.0, "share_price": 0.8976, "transaction_value": 20210.3616, "fetched_at": "2026-07-30T10:58:50.938834+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "ZERONDA, TYLER", "executive_title": "CHIEF FINANCIAL OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 22516.0, "share_price": 0.8976, "transaction_value": 20210.3616, "fetched_at": "2026-07-30T10:58:50.942620+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "VYNE", "name": "Vyne Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "STUART, IAIN", "executive_title": "CHIEF SCIENTIFIC OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 15405.0, "share_price": 0.8976, "transaction_value": 13827.528, "fetched_at": "2026-07-30T10:58:50.932389+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vyne/", "research_links": {"chart": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/", "report": "/terminal/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/report/", "factor": "/factors/ticker/ae9d8302-e8d3-4a23-9dc7-58eb5854397a/"}}, {"symbol": "INSM", "name": "Insmed Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "LEWIS, WILLIAM", "executive_title": "Director, Chair and CEO", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 6260.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:10:02.761692+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/insm/", "research_links": {"chart": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/", "report": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/report/", "factor": "/factors/ticker/4462d582-ffa0-4ad8-8e28-dc0a53589a12/"}}, {"symbol": "INSM", "name": "Insmed Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "LEWIS, WILLIAM", "executive_title": "Director, Chair and CEO", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 4440.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:10:02.759456+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/insm/", "research_links": {"chart": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/", "report": "/terminal/4462d582-ffa0-4ad8-8e28-dc0a53589a12/report/", "factor": "/factors/ticker/4462d582-ffa0-4ad8-8e28-dc0a53589a12/"}}, {"symbol": "ATRA", "name": "Atara Biotherapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "REDMILE, GROUP, LLC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 60.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-31T21:59:15.853072+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/atra/", "research_links": {"chart": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/", "report": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/report/", "factor": "/factors/ticker/61910527-1c5c-4eb2-89ea-15ea913b9982/"}}, {"symbol": "ATRA", "name": "Atara Biotherapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "REDMILE, GROUP, LLC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 195211.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-31T21:59:15.864170+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/atra/", "research_links": {"chart": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/", "report": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/report/", "factor": "/factors/ticker/61910527-1c5c-4eb2-89ea-15ea913b9982/"}}, {"symbol": "SRZN", "name": "Surrozen Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "TCG, CROSSOVER GP II, LLC", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 162500.0, "share_price": 21.25, "transaction_value": 3453125.0, "fetched_at": "2026-07-29T22:04:34.381866+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/srzn/", "research_links": {"chart": "/terminal/23b8ba9d-c1a6-4d8a-949d-a02dca1e8a5a/", "report": "/terminal/23b8ba9d-c1a6-4d8a-949d-a02dca1e8a5a/report/", "factor": "/factors/ticker/23b8ba9d-c1a6-4d8a-949d-a02dca1e8a5a/"}}, {"symbol": "NTLA", "name": "Intellia Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "DULAC, EDWARD J III", "executive_title": "EVP, Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 8111.0, "share_price": 11.25, "transaction_value": 91248.75, "fetched_at": "2026-07-31T10:50:47.038502+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/ntla/", "research_links": {"chart": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/", "report": "/terminal/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/report/", "factor": "/factors/ticker/17bb16ae-0669-4cc3-a11b-3c5d9d18d48c/"}}, {"symbol": "DYAI", "name": "Dyadic International Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "FRANCISCO, TRUST UNDER AGREEMENT DATED FEBRUARY 28, 1996", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 38016.0, "share_price": 1.3279, "transaction_value": 50481.4464, "fetched_at": "2026-07-30T10:57:47.054151+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dyai/", "research_links": {"chart": "/terminal/0df9ea28-5d7a-45f2-895e-d7204e29445f/", "report": "/terminal/0df9ea28-5d7a-45f2-895e-d7204e29445f/report/", "factor": "/factors/ticker/0df9ea28-5d7a-45f2-895e-d7204e29445f/"}}, {"symbol": "MLTX", "name": "MoonLake Immunotherapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "REICH, KRISTIAN", "executive_title": "Chief Scientific Officer", "security_type": "Class A ordinary shares, par value $0.0001 per share", "side_code": "D", "side": "Disposal", "shares": 2448.0, "share_price": 20.0, "transaction_value": 48960.0, "fetched_at": "2026-07-31T10:54:34.377412+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mltx/", "research_links": {"chart": "/terminal/00c0ba0e-839d-4b83-8101-db908d22fc0b/", "report": "/terminal/00c0ba0e-839d-4b83-8101-db908d22fc0b/report/", "factor": "/factors/ticker/00c0ba0e-839d-4b83-8101-db908d22fc0b/"}}, {"symbol": "ATRA", "name": "Atara Biotherapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "REDMILE, GROUP, LLC", "executive_title": "Director", "security_type": "Pre-Funded Warrants to Purchase Common Stock", "side_code": "D", "side": "Disposal", "shares": 38735.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T21:59:15.862523+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/atra/", "research_links": {"chart": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/", "report": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/report/", "factor": "/factors/ticker/61910527-1c5c-4eb2-89ea-15ea913b9982/"}}, {"symbol": "ATRA", "name": "Atara Biotherapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "REDMILE, GROUP, LLC", "executive_title": "Director", "security_type": "Pre-Funded Warrants to Purchase Common Stock", "side_code": "D", "side": "Disposal", "shares": 101089.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T21:59:15.868196+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/atra/", "research_links": {"chart": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/", "report": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/report/", "factor": "/factors/ticker/61910527-1c5c-4eb2-89ea-15ea913b9982/"}}, {"symbol": "ATRA", "name": "Atara Biotherapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "REDMILE, GROUP, LLC", "executive_title": "Director", "security_type": "Pre-Funded Warrants to Purchase Common Stock", "side_code": "D", "side": "Disposal", "shares": 55387.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T21:59:15.866119+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/atra/", "research_links": {"chart": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/", "report": "/terminal/61910527-1c5c-4eb2-89ea-15ea913b9982/report/", "factor": "/factors/ticker/61910527-1c5c-4eb2-89ea-15ea913b9982/"}}, {"symbol": "OMER", "name": "Omeros Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "BORGES, DAVID J.", "executive_title": "VP, Finance & CAO", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 105000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T11:01:59.007760+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/omer/", "research_links": {"chart": "/terminal/b322b82e-6812-408f-9c42-41c81bec7c83/", "report": "/terminal/b322b82e-6812-408f-9c42-41c81bec7c83/report/", "factor": "/factors/ticker/b322b82e-6812-408f-9c42-41c81bec7c83/"}}, {"symbol": "OMER", "name": "Omeros Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "CANCELMO, PETER B", "executive_title": "VP, General Counsel", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 105000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T11:01:59.009501+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/omer/", "research_links": {"chart": "/terminal/b322b82e-6812-408f-9c42-41c81bec7c83/", "report": "/terminal/b322b82e-6812-408f-9c42-41c81bec7c83/report/", "factor": "/factors/ticker/b322b82e-6812-408f-9c42-41c81bec7c83/"}}, {"symbol": "OMER", "name": "Omeros Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-22", "executive": "DEMOPULOS, GREGORY A MD", "executive_title": "Director, Chairman, CEO & President", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 1000000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T11:01:59.005584+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/omer/", "research_links": {"chart": "/terminal/b322b82e-6812-408f-9c42-41c81bec7c83/", "report": "/terminal/b322b82e-6812-408f-9c42-41c81bec7c83/report/", "factor": "/factors/ticker/b322b82e-6812-408f-9c42-41c81bec7c83/"}}, {"symbol": "MLTX", "name": "MoonLake Immunotherapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "REICH, KRISTIAN", "executive_title": "Chief Scientific Officer", "security_type": "Class A ordinary shares, par value $0.0001 per share", "side_code": "D", "side": "Disposal", "shares": 50000.0, "share_price": 20.02, "transaction_value": 1001000.0, "fetched_at": "2026-07-31T10:54:34.379598+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mltx/", "research_links": {"chart": "/terminal/00c0ba0e-839d-4b83-8101-db908d22fc0b/", "report": "/terminal/00c0ba0e-839d-4b83-8101-db908d22fc0b/report/", "factor": "/factors/ticker/00c0ba0e-839d-4b83-8101-db908d22fc0b/"}}, {"symbol": "MGTX", "name": "MeiraGTx Holdings PLC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "GIROUX, RICHARD", "executive_title": "CFO & COO", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 56000.0, "share_price": 12.51, "transaction_value": 700560.0, "fetched_at": "2026-07-31T10:59:03.267421+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mgtx/", "research_links": {"chart": "/terminal/c17b2e70-74a3-4bc4-a406-6ee0fb32abf1/", "report": "/terminal/c17b2e70-74a3-4bc4-a406-6ee0fb32abf1/report/", "factor": "/factors/ticker/c17b2e70-74a3-4bc4-a406-6ee0fb32abf1/"}}, {"symbol": "CYTK", "name": "Cytokinetics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "MALIK, FADY IBRAHAM", "executive_title": "EVP Research & Development", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3500.0, "share_price": 80.59, "transaction_value": 282065.0, "fetched_at": "2026-07-30T21:50:16.828298+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cytk/", "research_links": {"chart": "/terminal/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/", "report": "/terminal/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/report/", "factor": "/factors/ticker/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/"}}, {"symbol": "CYTK", "name": "Cytokinetics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "MALIK, FADY IBRAHAM", "executive_title": "EVP Research & Development", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3500.0, "share_price": 7.8, "transaction_value": 27300.0, "fetched_at": "2026-07-30T21:50:16.831936+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cytk/", "research_links": {"chart": "/terminal/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/", "report": "/terminal/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/report/", "factor": "/factors/ticker/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/"}}, {"symbol": "RANI", "name": "Rani Therapeutics Holdings Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "IMRAN, MIR A", "executive_title": "Director, 10% Owner", "security_type": "Class A Common Stock", "side_code": "A", "side": "Acquisition", "shares": 36000.0, "share_price": 0.69, "transaction_value": 24840.0, "fetched_at": "2026-07-31T21:56:50.115989+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rani/", "research_links": {"chart": "/terminal/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/", "report": "/terminal/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/report/", "factor": "/factors/ticker/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/"}}, {"symbol": "ABEO", "name": "Abeona Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "VAZZANO, JOSEPH WALTER", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1478.0, "share_price": 6.53, "transaction_value": 9651.34, "fetched_at": "2026-07-29T22:03:23.997870+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/abeo/", "research_links": {"chart": "/terminal/6e8cdb5b-8663-41f7-9494-52144fcbd685/", "report": "/terminal/6e8cdb5b-8663-41f7-9494-52144fcbd685/report/", "factor": "/factors/ticker/6e8cdb5b-8663-41f7-9494-52144fcbd685/"}}, {"symbol": "CYTK", "name": "Cytokinetics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "MALIK, FADY IBRAHAM", "executive_title": "EVP Research & Development", "security_type": "Non-Qualified Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 3500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:50:16.830401+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cytk/", "research_links": {"chart": "/terminal/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/", "report": "/terminal/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/report/", "factor": "/factors/ticker/3752e5e7-76ec-446c-b51b-d4b3bc0dc8a4/"}}, {"symbol": "OTLK", "name": "OUTLOOK THERAPEUTICS INC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "JAHR, ROBERT CHARLES", "executive_title": "Director, Chief Executive Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 100000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T10:48:24.616399+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/otlk/", "research_links": {"chart": "/terminal/428d3268-e95e-4507-abb1-f58bce42dc91/", "report": "/terminal/428d3268-e95e-4507-abb1-f58bce42dc91/report/", "factor": "/factors/ticker/428d3268-e95e-4507-abb1-f58bce42dc91/"}}, {"symbol": "OTLK", "name": "OUTLOOK THERAPEUTICS INC", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "KENYON, LAWRENCE A", "executive_title": "Director, Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 210078.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T10:48:24.612071+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/otlk/", "research_links": {"chart": "/terminal/428d3268-e95e-4507-abb1-f58bce42dc91/", "report": "/terminal/428d3268-e95e-4507-abb1-f58bce42dc91/report/", "factor": "/factors/ticker/428d3268-e95e-4507-abb1-f58bce42dc91/"}}, {"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "SACHDEV, AMIT", "executive_title": "EVP Chief Patient & Ext Af Off", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 8251.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:47:04.863424+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}, {"symbol": "VRTX", "name": "Vertex Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-21", "executive": "TATSIS, OURANIA", "executive_title": "EVP, Chief Reg. & Quality Off.", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 8251.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:47:04.871867+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vrtx/", "research_links": {"chart": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/", "report": "/terminal/85cf1839-5d87-4b1b-8118-600d01682cf0/report/", "factor": "/factors/ticker/85cf1839-5d87-4b1b-8118-600d01682cf0/"}}, {"symbol": "JSPR", "name": "Jasper Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "CRUTCHER, PATRICK J", "executive_title": "Director", "security_type": "Non-Voting Convertible Preferred Stock", "side_code": "A", "side": "Acquisition", "shares": 888.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-31T22:08:13.436938+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/jspr/", "research_links": {"chart": "/terminal/e6bc52d4-759d-4082-a252-e3fd6873465d/", "report": "/terminal/e6bc52d4-759d-4082-a252-e3fd6873465d/report/", "factor": "/factors/ticker/e6bc52d4-759d-4082-a252-e3fd6873465d/"}}, {"symbol": "JSPR", "name": "Jasper Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "ROS, MATTHEW E", "executive_title": "Chief Operating Officer", "security_type": "Non-Voting Convertible Preferred Stock", "side_code": "A", "side": "Acquisition", "shares": 881.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-31T22:08:13.444216+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/jspr/", "research_links": {"chart": "/terminal/e6bc52d4-759d-4082-a252-e3fd6873465d/", "report": "/terminal/e6bc52d4-759d-4082-a252-e3fd6873465d/report/", "factor": "/factors/ticker/e6bc52d4-759d-4082-a252-e3fd6873465d/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 70200.0, "share_price": 29.96, "transaction_value": 2103192.0, "fetched_at": "2026-07-30T22:01:34.649745+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 31885.0, "share_price": 31.05, "transaction_value": 990029.25, "fetched_at": "2026-07-30T22:01:34.659168+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 80000.0, "share_price": 11.17, "transaction_value": 893600.0, "fetched_at": "2026-07-30T22:01:34.653713+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "MLTX", "name": "MoonLake Immunotherapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "REICH, KRISTIAN", "executive_title": "Chief Scientific Officer", "security_type": "Class A ordinary shares, par value $0.0001 per share", "side_code": "D", "side": "Disposal", "shares": 43700.0, "share_price": 20.09, "transaction_value": 877933.0, "fetched_at": "2026-07-31T10:54:34.381506+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mltx/", "research_links": {"chart": "/terminal/00c0ba0e-839d-4b83-8101-db908d22fc0b/", "report": "/terminal/00c0ba0e-839d-4b83-8101-db908d22fc0b/report/", "factor": "/factors/ticker/00c0ba0e-839d-4b83-8101-db908d22fc0b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 680.0, "share_price": 547.698, "transaction_value": 372434.64, "fetched_at": "2026-07-30T21:48:43.240900+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 25000.0, "share_price": 11.9, "transaction_value": 297500.0, "fetched_at": "2026-07-30T22:01:34.646898+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 545.0, "share_price": 544.714, "transaction_value": 296869.13, "fetched_at": "2026-07-30T21:48:43.245602+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 280.0, "share_price": 555.05, "transaction_value": 155414.0, "fetched_at": "2026-07-30T21:48:43.233003+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 275.0, "share_price": 545.7092, "transaction_value": 150070.03, "fetched_at": "2026-07-30T21:48:43.244031+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 269.0, "share_price": 547.0788, "transaction_value": 147164.1972, "fetched_at": "2026-07-30T21:48:43.242458+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 2915.0, "share_price": 31.71, "transaction_value": 92434.65, "fetched_at": "2026-07-30T22:01:34.651771+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 153.0, "share_price": 550.0138, "transaction_value": 84152.1114, "fetched_at": "2026-07-30T21:48:43.237956+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 140.0, "share_price": 542.7459, "transaction_value": 75984.426, "fetched_at": "2026-07-30T21:48:43.236345+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 110.0, "share_price": 543.7929, "transaction_value": 59817.219, "fetched_at": "2026-07-30T21:48:43.234604+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "ANIX", "name": "Anixa Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "TITTERTON, LEWIS H JR", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 12000.0, "share_price": 3.47, "transaction_value": 41640.0, "fetched_at": "2026-07-31T21:59:48.028377+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/anix/", "research_links": {"chart": "/terminal/01375501-71ca-44d9-ab28-f75ee33bd267/", "report": "/terminal/01375501-71ca-44d9-ab28-f75ee33bd267/report/", "factor": "/factors/ticker/01375501-71ca-44d9-ab28-f75ee33bd267/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 47.0, "share_price": 548.8719, "transaction_value": 25796.9793, "fetched_at": "2026-07-30T21:48:43.239327+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "ANIX", "name": "Anixa Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KUMAR, AMIT", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5000.0, "share_price": 3.46, "transaction_value": 17300.0, "fetched_at": "2026-07-31T21:59:48.038463+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/anix/", "research_links": {"chart": "/terminal/01375501-71ca-44d9-ab28-f75ee33bd267/", "report": "/terminal/01375501-71ca-44d9-ab28-f75ee33bd267/report/", "factor": "/factors/ticker/01375501-71ca-44d9-ab28-f75ee33bd267/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1.0, "share_price": 550.72, "transaction_value": 550.72, "fetched_at": "2026-07-30T21:48:43.230996+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 80000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T22:01:34.657341+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "NAMS", "name": "NewAmsterdam Pharma Company N.V. Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-20", "executive": "KOOIJ, LOUISE FREDERIKA", "executive_title": "Chief Accounting Officer", "security_type": "Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 25000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T22:01:34.655619+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nams/", "research_links": {"chart": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/", "report": "/terminal/b909b0d6-ac7c-43e4-b8f0-3908e0989269/report/", "factor": "/factors/ticker/b909b0d6-ac7c-43e4-b8f0-3908e0989269/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "COLLARD, CRAIG A", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 13797.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-29T22:10:41.911329+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "DUARTE, IRA", "executive_title": "EVP, Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3874.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-29T22:10:41.918513+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "FORBES, WILLIAM P", "executive_title": "EVP, Chief Development Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3874.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-29T22:10:41.923633+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "DUARTE, IRA", "executive_title": "EVP, Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1101.0, "share_price": 0.47, "transaction_value": 517.47, "fetched_at": "2026-07-29T22:10:41.916407+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "FORBES, WILLIAM P", "executive_title": "EVP, Chief Development Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1101.0, "share_price": 0.47, "transaction_value": 517.47, "fetched_at": "2026-07-29T22:10:41.922211+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "COLLARD, CRAIG A", "executive_title": "Director, Chief Executive Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 13797.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-29T22:10:41.925340+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "DUARTE, IRA", "executive_title": "EVP, Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 3874.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-29T22:10:41.914518+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "FORBES, WILLIAM P", "executive_title": "EVP, Chief Development Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 3874.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-29T22:10:41.920401+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 50000.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-30T21:48:43.248546+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "MNKD", "name": "MannKind Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "BINDER, STEVEN B.", "executive_title": "Director", "security_type": "Common Stock, $0.01 Par Value", "side_code": "D", "side": "Disposal", "shares": 52485.0, "share_price": 4.06, "transaction_value": 213089.1, "fetched_at": "2026-07-31T10:58:00.678733+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mnkd/", "research_links": {"chart": "/terminal/ea6f90ee-f127-429e-b2af-8d9e4052576e/", "report": "/terminal/ea6f90ee-f127-429e-b2af-8d9e4052576e/report/", "factor": "/factors/ticker/ea6f90ee-f127-429e-b2af-8d9e4052576e/"}}, {"symbol": "FULC", "name": "Fulcrum Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "TANG, KEVIN", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 50945.0, "share_price": 3.52, "transaction_value": 179326.4, "fetched_at": "2026-07-31T11:08:37.892455+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fulc/", "research_links": {"chart": "/terminal/b9bb7bef-e478-4ef9-ada9-0036dc78ff25/", "report": "/terminal/b9bb7bef-e478-4ef9-ada9-0036dc78ff25/report/", "factor": "/factors/ticker/b9bb7bef-e478-4ef9-ada9-0036dc78ff25/"}}, {"symbol": "MNKD", "name": "MannKind Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "THOMSON, DAVID", "executive_title": "EVP Genl Counsel & Secretary", "security_type": "Common Stock, $0.01 Par Value", "side_code": "D", "side": "Disposal", "shares": 24109.0, "share_price": 4.05, "transaction_value": 97641.45, "fetched_at": "2026-07-31T10:58:00.680839+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mnkd/", "research_links": {"chart": "/terminal/ea6f90ee-f127-429e-b2af-8d9e4052576e/", "report": "/terminal/ea6f90ee-f127-429e-b2af-8d9e4052576e/report/", "factor": "/factors/ticker/ea6f90ee-f127-429e-b2af-8d9e4052576e/"}}, {"symbol": "RANI", "name": "Rani Therapeutics Holdings Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "IMRAN, TALAT", "executive_title": "Director, Chief Executive Officer", "security_type": "Class A Common Stock", "side_code": "A", "side": "Acquisition", "shares": 35000.0, "share_price": 0.7198, "transaction_value": 25193.0, "fetched_at": "2026-07-31T21:56:50.120774+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rani/", "research_links": {"chart": "/terminal/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/", "report": "/terminal/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/report/", "factor": "/factors/ticker/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/"}}, {"symbol": "DNA", "name": "Ginkgo Bioworks Holdings", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "COEN, STEVEN P.", "executive_title": "See remarks", "security_type": "Class A Common Stock", "side_code": "D", "side": "Disposal", "shares": 752.0, "share_price": 7.903, "transaction_value": 5943.056, "fetched_at": "2026-07-29T21:54:11.778288+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dna/", "research_links": {"chart": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/", "report": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/report/", "factor": "/factors/ticker/3264af35-eb5a-4c64-8c7b-379213ed9bd9/"}}, {"symbol": "BCDA", "name": "Biocardia\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "ALTMAN, PETER", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 500.0, "share_price": 0.83, "transaction_value": 415.0, "fetched_at": "2026-07-30T11:02:02.370859+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcda/", "research_links": {"chart": "/terminal/fa621307-fa10-49b7-8abf-d5cc5855702d/", "report": "/terminal/fa621307-fa10-49b7-8abf-d5cc5855702d/report/", "factor": "/factors/ticker/fa621307-fa10-49b7-8abf-d5cc5855702d/"}}, {"symbol": "LYEL", "name": "Lyell Immunopharma Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "INNOVATIVE, CELLULAR THERAPEUTICS HOLDINGS LTD", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10.0, "share_price": 13.7, "transaction_value": 137.0, "fetched_at": "2026-07-31T11:11:09.288700+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lyel/", "research_links": {"chart": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/", "report": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/report/", "factor": "/factors/ticker/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/"}}, {"symbol": "ARTL", "name": "Artelo Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "BLAYNEY, DOUGLAS", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 136.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:04:28.154746+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/artl/", "research_links": {"chart": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/", "report": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/report/", "factor": "/factors/ticker/08f21f1a-3a3b-4928-aeda-4b66067c72ea/"}}, {"symbol": "ARTL", "name": "Artelo Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "EMANUELE, ROBERT MARTIN", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 136.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:04:28.150124+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/artl/", "research_links": {"chart": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/", "report": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/report/", "factor": "/factors/ticker/08f21f1a-3a3b-4928-aeda-4b66067c72ea/"}}, {"symbol": "ARTL", "name": "Artelo Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "FAVORITO, TAMARA A", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 136.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:04:28.157373+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/artl/", "research_links": {"chart": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/", "report": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/report/", "factor": "/factors/ticker/08f21f1a-3a3b-4928-aeda-4b66067c72ea/"}}, {"symbol": "ARTL", "name": "Artelo Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "KELLY, STEVEN", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 136.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:04:28.147112+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/artl/", "research_links": {"chart": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/", "report": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/report/", "factor": "/factors/ticker/08f21f1a-3a3b-4928-aeda-4b66067c72ea/"}}, {"symbol": "ARTL", "name": "Artelo Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "MATSUI, CONNIE", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 136.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:04:28.159884+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/artl/", "research_links": {"chart": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/", "report": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/report/", "factor": "/factors/ticker/08f21f1a-3a3b-4928-aeda-4b66067c72ea/"}}, {"symbol": "ARTL", "name": "Artelo Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "REYES, GREGORY", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 136.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:04:28.152281+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/artl/", "research_links": {"chart": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/", "report": "/terminal/08f21f1a-3a3b-4928-aeda-4b66067c72ea/report/", "factor": "/factors/ticker/08f21f1a-3a3b-4928-aeda-4b66067c72ea/"}}, {"symbol": "MDGL", "name": "Madrigal Pharmaceuticals Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "SIBOLD, WILLIAM JOHN", "executive_title": "Director, President and CEO", "security_type": "Performance Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 50000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:48:43.247087+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/mdgl/", "research_links": {"chart": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/", "report": "/terminal/395e904b-a8e7-4795-b37b-55f3445d832b/report/", "factor": "/factors/ticker/395e904b-a8e7-4795-b37b-55f3445d832b/"}}, {"symbol": "RANI", "name": "Rani Therapeutics Holdings Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "MAESTAS, NICHOLAS", "executive_title": "Chief Financial Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 2000000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T21:56:50.118585+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rani/", "research_links": {"chart": "/terminal/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/", "report": "/terminal/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/report/", "factor": "/factors/ticker/cd5daa06-74f9-4b4b-a6a7-1e66f4769806/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "EPPERLY, MELISSA B,", "executive_title": "Director", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 543.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:10:43.123400+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "MOMTAZEE, JAMES C", "executive_title": "Director", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 405.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:10:43.125491+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "ROIV", "name": "Roivant Sciences Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-17", "executive": "OREN, ILAN", "executive_title": "Director", "security_type": "Common Shares", "side_code": "A", "side": "Acquisition", "shares": 775.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:10:43.120406+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/roiv/", "research_links": {"chart": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/", "report": "/terminal/897bc5d3-fde4-4979-90b4-ea8aa4b74697/report/", "factor": "/factors/ticker/897bc5d3-fde4-4979-90b4-ea8aa4b74697/"}}, {"symbol": "DNA", "name": "Ginkgo Bioworks Holdings", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "COEN, STEVEN P.", "executive_title": "See remarks", "security_type": "Class A Common Stock", "side_code": "A", "side": "Acquisition", "shares": 1174.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-29T21:54:11.783415+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dna/", "research_links": {"chart": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/", "report": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/report/", "factor": "/factors/ticker/3264af35-eb5a-4c64-8c7b-379213ed9bd9/"}}, {"symbol": "DNA", "name": "Ginkgo Bioworks Holdings", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "COEN, STEVEN P.", "executive_title": "See remarks", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 1174.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-29T21:54:11.787835+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dna/", "research_links": {"chart": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/", "report": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/report/", "factor": "/factors/ticker/3264af35-eb5a-4c64-8c7b-379213ed9bd9/"}}, {"symbol": "DNA", "name": "Ginkgo Bioworks Holdings", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "COEN, STEVEN P.", "executive_title": "See remarks", "security_type": "Class A Common Stock", "side_code": "A", "side": "Acquisition", "shares": 312.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-29T21:54:11.781324+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dna/", "research_links": {"chart": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/", "report": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/report/", "factor": "/factors/ticker/3264af35-eb5a-4c64-8c7b-379213ed9bd9/"}}, {"symbol": "DNA", "name": "Ginkgo Bioworks Holdings", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "COEN, STEVEN P.", "executive_title": "See remarks", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 312.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-29T21:54:11.785502+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/dna/", "research_links": {"chart": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/", "report": "/terminal/3264af35-eb5a-4c64-8c7b-379213ed9bd9/report/", "factor": "/factors/ticker/3264af35-eb5a-4c64-8c7b-379213ed9bd9/"}}, {"symbol": "VOR", "name": "Vor Biopharma Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "RA, CAPITAL MANAGEMENT, L.P.", "executive_title": "10% Owner", "security_type": "Pre-Funded Warrant (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 2100000.0, "share_price": 5.0, "transaction_value": 10500000.0, "fetched_at": "2026-07-31T11:01:47.495255+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vor/", "research_links": {"chart": "/terminal/57c99d55-6f56-41ab-8d52-0f601d97cc61/", "report": "/terminal/57c99d55-6f56-41ab-8d52-0f601d97cc61/report/", "factor": "/factors/ticker/57c99d55-6f56-41ab-8d52-0f601d97cc61/"}}, {"symbol": "FULC", "name": "Fulcrum Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "TANG, KEVIN", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 116671.0, "share_price": 3.56, "transaction_value": 415348.76, "fetched_at": "2026-07-31T11:08:37.896850+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/fulc/", "research_links": {"chart": "/terminal/b9bb7bef-e478-4ef9-ada9-0036dc78ff25/", "report": "/terminal/b9bb7bef-e478-4ef9-ada9-0036dc78ff25/report/", "factor": "/factors/ticker/b9bb7bef-e478-4ef9-ada9-0036dc78ff25/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "WARMUTH, MARKUS", "executive_title": "Director, President & CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 9500.0, "share_price": 23.1809, "transaction_value": 220218.55, "fetched_at": "2026-07-31T10:52:40.239187+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1877.0, "share_price": 114.73, "transaction_value": 215348.21, "fetched_at": "2026-07-30T11:11:16.523528+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "ISSA, MOHAMED KHAIRIE", "executive_title": "EVP, Head of U.S. Commercial", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1093.0, "share_price": 115.01, "transaction_value": 125705.93, "fetched_at": "2026-07-30T11:11:16.501022+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "VOR", "name": "Vor Biopharma Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "RA, CAPITAL MANAGEMENT, L.P.", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 213.0, "share_price": 19.75, "transaction_value": 4206.75, "fetched_at": "2026-07-31T11:01:47.492371+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vor/", "research_links": {"chart": "/terminal/57c99d55-6f56-41ab-8d52-0f601d97cc61/", "report": "/terminal/57c99d55-6f56-41ab-8d52-0f601d97cc61/report/", "factor": "/factors/ticker/57c99d55-6f56-41ab-8d52-0f601d97cc61/"}}, {"symbol": "VOR", "name": "Vor Biopharma Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "RA, CAPITAL MANAGEMENT, L.P.", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2100000.0, "share_price": 0.002, "transaction_value": 4200.0, "fetched_at": "2026-07-31T11:01:47.487693+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/vor/", "research_links": {"chart": "/terminal/57c99d55-6f56-41ab-8d52-0f601d97cc61/", "report": "/terminal/57c99d55-6f56-41ab-8d52-0f601d97cc61/report/", "factor": "/factors/ticker/57c99d55-6f56-41ab-8d52-0f601d97cc61/"}}, {"symbol": "LYEL", "name": "Lyell Immunopharma Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "INNOVATIVE, CELLULAR THERAPEUTICS HOLDINGS LTD", "executive_title": "10% Owner", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10.0, "share_price": 13.73, "transaction_value": 137.3, "fetched_at": "2026-07-31T11:11:09.292013+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/lyel/", "research_links": {"chart": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/", "report": "/terminal/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/report/", "factor": "/factors/ticker/918e8a8f-6a79-44de-97d5-69c0a0d00ca0/"}}, {"symbol": "ADMA", "name": "ADMA Biologics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "KOHLER, TERRY", "executive_title": "CFO and Treasurer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 85130.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:44.914346+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/adma/", "research_links": {"chart": "/terminal/6a4cd0c8-4d16-49ec-9f00-c3984014c762/", "report": "/terminal/6a4cd0c8-4d16-49ec-9f00-c3984014c762/report/", "factor": "/factors/ticker/6a4cd0c8-4d16-49ec-9f00-c3984014c762/"}}, {"symbol": "ADMA", "name": "ADMA Biologics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "KOHLER, TERRY", "executive_title": "CFO and Treasurer", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 136363.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:44.910643+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/adma/", "research_links": {"chart": "/terminal/6a4cd0c8-4d16-49ec-9f00-c3984014c762/", "report": "/terminal/6a4cd0c8-4d16-49ec-9f00-c3984014c762/report/", "factor": "/factors/ticker/6a4cd0c8-4d16-49ec-9f00-c3984014c762/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "BRAMS, MATTHEW", "executive_title": "EVP and Chief Medical Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 26400.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.607370+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "BRAMS, MATTHEW", "executive_title": "EVP and Chief Medical Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 53600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.606026+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CALLAHAN, JENNIFER L.", "executive_title": "EVP and CFO", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 19800.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.613687+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CALLAHAN, JENNIFER L.", "executive_title": "EVP and CFO", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 40200.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.611533+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "DOWNEY, BRYAN WADE", "executive_title": "EVP & Chief Commercial Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 67000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.622245+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "DOWNEY, BRYAN WADE", "executive_title": "EVP & Chief Commercial Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 33000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.602186+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARGROVES, THOMAS JEFFREY", "executive_title": "Director", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 20000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.609529+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "LAWRENCE, BRYAN JAY", "executive_title": "Director", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 20000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.604362+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "SCHAFFER, SHANE J.", "executive_title": "Director, Chief Executive Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 197650.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.598183+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "SCHAFFER, SHANE J.", "executive_title": "Director, Chief Executive Officer", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 97350.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.624552+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "SILVA, RAUL R.", "executive_title": "EVP and CSO", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 26400.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.620210+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "SILVA, RAUL R.", "executive_title": "EVP and CSO", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 53600.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.618092+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "CING", "name": "Cingulate Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "WERTH, PETER J.", "executive_title": "Director", "security_type": "Stock Option (right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 20000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:03:15.615861+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/cing/", "research_links": {"chart": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/", "report": "/terminal/94edcefe-abec-46ad-b6ae-8b911d3792ac/report/", "factor": "/factors/ticker/94edcefe-abec-46ad-b6ae-8b911d3792ac/"}}, {"symbol": "IMRX", "name": "Immuneering Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "GENGOS, ANDREW", "executive_title": "Chief Financial Officer", "security_type": "Stock Option", "side_code": "A", "side": "Acquisition", "shares": 650000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T21:47:09.985705+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imrx/", "research_links": {"chart": "/terminal/a1506a8d-4307-4bf0-8478-ea7b8415652e/", "report": "/terminal/a1506a8d-4307-4bf0-8478-ea7b8415652e/report/", "factor": "/factors/ticker/a1506a8d-4307-4bf0-8478-ea7b8415652e/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "BASI, RAMITPAL K", "executive_title": "EVP, Human Resources", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 12479.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.510407+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "BASI, RAMITPAL K", "executive_title": "EVP, Human Resources", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 4991.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.508967+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "BASI, RAMITPAL K", "executive_title": "EVP, Human Resources", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 21548.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.512105+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 13403.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.495991+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 33508.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.497626+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CAGNONI, PABLO J", "executive_title": "President, Global Head of R&D", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 57861.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.499395+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "GARDNER, DAVID H", "executive_title": "EVP, Chief Strategy Officer", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 18487.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.515148+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "GARDNER, DAVID H", "executive_title": "EVP, Chief Strategy Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7395.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.513615+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "GARDNER, DAVID H", "executive_title": "EVP, Chief Strategy Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 31923.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.516874+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HOFFMAN, RICHARD A.", "executive_title": "EVP & General Counsel", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7395.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.519091+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HOFFMAN, RICHARD A.", "executive_title": "EVP & General Counsel", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 31923.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.528398+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HOFFMAN, RICHARD A.", "executive_title": "EVP & General Counsel", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 18487.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.521611+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "ISSA, MOHAMED KHAIRIE", "executive_title": "EVP, Head of U.S. Commercial", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 33918.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.507486+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "ISSA, MOHAMED KHAIRIE", "executive_title": "EVP, Head of U.S. Commercial", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7857.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.503188+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "ISSA, MOHAMED KHAIRIE", "executive_title": "EVP, Head of U.S. Commercial", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 19643.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.505343+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MAYES, PATRICK A", "executive_title": "EVP & Chief Scientific Officer", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 14790.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.492507+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MAYES, PATRICK A", "executive_title": "EVP & Chief Scientific Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 25538.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.494470+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MAYES, PATRICK A", "executive_title": "EVP & Chief Scientific Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5916.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.490479+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MEURY, WILLIAM", "executive_title": "Director, Chief Executive Officer", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 80421.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.532155+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MEURY, WILLIAM", "executive_title": "Director, Chief Executive Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 77148.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.533642+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MEURY, WILLIAM", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 26807.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.529914+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Performance Shares", "side_code": "A", "side": "Acquisition", "shares": 24496.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.487088+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 9798.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.481592+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "STEIN, STEVEN H", "executive_title": "CMO & Head of Late-Stage Dev.", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 42298.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.488905+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "TRAY, THOMAS", "executive_title": "Principal Accounting Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 4079.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.525108+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "INCY", "name": "Incyte Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "TRAY, THOMAS", "executive_title": "Principal Accounting Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2834.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T11:11:16.526538+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/incy/", "research_links": {"chart": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/", "report": "/terminal/da05e924-2410-4fdc-ae9c-7a87bb611124/report/", "factor": "/factors/ticker/da05e924-2410-4fdc-ae9c-7a87bb611124/"}}, {"symbol": "JSPR", "name": "Jasper Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "CRUTCHER, PATRICK J", "executive_title": "Director", "security_type": "Stock Option (Right to Buy", "side_code": "A", "side": "Acquisition", "shares": 15000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T22:08:13.446887+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/jspr/", "research_links": {"chart": "/terminal/e6bc52d4-759d-4082-a252-e3fd6873465d/", "report": "/terminal/e6bc52d4-759d-4082-a252-e3fd6873465d/report/", "factor": "/factors/ticker/e6bc52d4-759d-4082-a252-e3fd6873465d/"}}, {"symbol": "PCVX", "name": "Vaxcyte\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "MARKELS, JOHN", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 23029.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T21:53:36.436018+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/pcvx/", "research_links": {"chart": "/terminal/9fe6f492-28da-4185-9841-d4f3b88a2f16/", "report": "/terminal/9fe6f492-28da-4185-9841-d4f3b88a2f16/report/", "factor": "/factors/ticker/9fe6f492-28da-4185-9841-d4f3b88a2f16/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 29747.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.538514+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 11650.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.526521+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 29555.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.550996+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 29747.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.540884+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 11650.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.528515+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 14777.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.524657+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 7639.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.542645+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 7639.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.544899+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 21000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.532729+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 19441.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.547737+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 21000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.530361+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 17786.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.534828+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}, {"symbol": "STOK", "name": "Stoke Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "HARRISON, SETH LORING", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "A", "side": "Acquisition", "shares": 29555.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:50:11.552497+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/stok/", "research_links": {"chart": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/", "report": "/terminal/5002c68e-a29a-403d-a6d0-0040a88f124b/report/", "factor": "/factors/ticker/5002c68e-a29a-403d-a6d0-0040a88f124b/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}